• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国成人活体供肝移植的变化:发现增加利用率的机会。

Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization.

机构信息

Saint Louis University Transplant Center, SSM-Saint Louis University Hospital, St. Louis, Missouri, USA.

Organ Transplant Center, University of Iowa, Iowa City, Iowa, USA.

出版信息

Clin Transplant. 2023 Jul;37(7):e14924. doi: 10.1111/ctr.14924. Epub 2023 Feb 22.

DOI:10.1111/ctr.14924
PMID:36733213
Abstract

In the United States, living donor liver transplantation (LDLT) is limited to transplant centers with specific experience. However, the impact of recipient characteristics on procedure selection (LDLT vs. deceased donor liver transplant [DDLT]) within these centers has not been described. Transplant registry data for centers that performed ≥1 LDLT in 2002-2019 were analyzed using hierarchal regression modeling to quantify the impact of patient and center factors on the adjusted odds ratio (aOR) of LDLT (vs DDLT). Among 73,681 adult recipients, only 4% underwent LDLT, varying from <1% to >60% of total liver transplants. After risk adjustment, the likelihood of receiving an LDLT rose by 73% in recent years (aOR 1.73 for 2014-2019 vs. 2002-2007) but remained lower for older adults, men, racial and ethnic minorities, and obese patients. LDLT was less commonly used in patients with hepatocellular carcinoma or alcoholic cirrhosis, and more frequently in those with hepatitis C and with lower severity of illness (Model for End-Stage Liver Disease (MELD) score < 15). Patients with public insurance, lower educational achievement, and residence in the Northwest and Southeast had decreased access. While some differences in access to LDLT reflect clinical factors, further exploration into disparities in LDLT utilization based on center practice and socioeconomic determinants of health is needed.

摘要

在美国,活体供肝移植(LDLT)仅限于具有特定经验的移植中心。然而,在这些中心内,受者特征对手术选择(LDLT 与已故供体肝移植[DDLT])的影响尚未描述。对 2002 年至 2019 年间进行了≥1 例 LDLT 的中心的移植登记数据进行了层次回归建模分析,以量化患者和中心因素对 LDLT(与 DDLT 相比)调整后的优势比(aOR)的影响。在 73681 名成年受者中,只有 4%接受了 LDLT,占总肝移植的比例从<1%到>60%不等。在风险调整后,近年来接受 LDLT 的可能性增加了 73%(2014-2019 年的 aOR 为 1.73,而 2002-2007 年为 1.73),但年龄较大、男性、种族和少数民族以及肥胖患者的可能性仍较低。LDLT 在肝细胞癌或酒精性肝硬化患者中较少使用,而在丙型肝炎患者和疾病严重程度较低(终末期肝病模型[MELD]评分<15)的患者中更为常见。有公共保险、教育程度较低以及居住在西北部和东南部的患者获得 LDLT 的机会减少。尽管 LDLT 获得机会的一些差异反映了临床因素,但仍需要进一步探讨基于中心实践和健康的社会经济决定因素的 LDLT 利用差异。

相似文献

1
Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization.美国成人活体供肝移植的变化:发现增加利用率的机会。
Clin Transplant. 2023 Jul;37(7):e14924. doi: 10.1111/ctr.14924. Epub 2023 Feb 22.
2
Sex and racial disparities in living donor liver transplantation in the United States.美国活体供肝移植中的性别和种族差异。
Liver Transpl. 2023 Nov 1;29(11):1172-1180. doi: 10.1097/LVT.0000000000000197. Epub 2023 Jun 29.
3
The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.美国活体供肝移植受者终末期肾病的风险。
Am J Transplant. 2015 Oct;15(10):2732-8. doi: 10.1111/ajt.13314. Epub 2015 May 12.
4
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.在终末期肝病模型分配时代,活体捐赠对肝移植受者生存获益的影响。
Hepatology. 2011 Oct;54(4):1313-21. doi: 10.1002/hep.24494.
5
A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.比较死亡供体和活体供体肝移植受者的慢性肾脏病发生率和严重程度:时间很重要。
Turk J Med Sci. 2021 Apr 30;51(2):610-622. doi: 10.3906/sag-2007-82.
6
Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.在乙肝流行地区,对终末期肝病模型评分≥35的患者进行活体供肝与尸体供肝肝移植的短期和长期疗效比较
Ann Surg. 2017 Jan;265(1):173-177. doi: 10.1097/SLA.0000000000001671.
7
Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.使用活体供肝移植的情况因可供使用的尸体供肝移植而异。
Liver Transpl. 2012 Feb;18(2):160-5. doi: 10.1002/lt.22455.
8
Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.在一个器官严重短缺的地区,对于模型预测终末期肝病评分(MELD)超过 30 的患者,活体肝移植的生存获益:一项回顾性队列研究。
Int J Surg. 2023 Nov 1;109(11):3459-3466. doi: 10.1097/JS9.0000000000000634.
9
Neighborhood-level social determinants of health measures independently predict receipt of living donor liver transplantation in the United States.社区层面的健康决定因素指标可独立预测在美国接受活体供肝移植的情况。
Liver Transpl. 2024 Jun 1;30(6):618-627. doi: 10.1097/LVT.0000000000000313. Epub 2023 Dec 18.
10
Racial and ethnic disparities in access to and utilization of living donor liver transplants.活体供肝移植在获取和利用方面的种族和民族差异。
Liver Transpl. 2015 Jul;21(7):904-13. doi: 10.1002/lt.24147. Epub 2015 Jun 9.

引用本文的文献

1
Liver Transplantation for Cancer-Current Challenges and Emerging Solutions.癌症的肝移植——当前挑战与新出现的解决办法
J Clin Med. 2025 Jul 29;14(15):5365. doi: 10.3390/jcm14155365.
2
Depressive and anxiety symptoms mediate the relationship between family support and alcohol relapse in transplant recipients with alcohol-associated liver disease.抑郁和焦虑症状在酒精相关性肝病移植受者中调节家庭支持与酒精复发之间的关系。
Sci Rep. 2025 Aug 5;15(1):28546. doi: 10.1038/s41598-025-14345-w.
3
Donor-specific digital twin for living donor liver transplant recovery.
用于活体肝移植恢复的供体特异性数字孪生模型。
Biol Methods Protoc. 2025 May 10;10(1):bpaf037. doi: 10.1093/biomethods/bpaf037. eCollection 2025.
4
Expanding Opportunities for Living Donation: Recommendations From the 2023 Santander Summit to Ensure Donor Protections, Informed Decision Making, and Equitable Access.扩大活体捐赠机会:2023年桑坦德峰会关于确保捐赠者保护、知情决策和公平获取的建议
Transplantation. 2025 Jan 1;109(1):22-35. doi: 10.1097/TP.0000000000005124. Epub 2024 Oct 22.
5
Usefulness of Diffusion-Weighted Imaging in Evaluating Acute Cellular Rejection and Monitoring Treatment Response in Liver Transplant Recipients.扩散加权成像在评估肝移植受者急性细胞排斥反应及监测治疗反应中的应用价值
Diagnostics (Basel). 2024 Apr 11;14(8):807. doi: 10.3390/diagnostics14080807.